What You Should Know:
– Healthcare technology company Komodo Health today launches a new product, National Drug Projections, bringing its customers a clear, complete, and detailed view of how many prescriptions are filled across the country for any group of medications.
-The new solution unlocks real-time market landscape intelligence, such as prescription volume, units dispensed, and new patient starts, to deliver an in-depth understanding of treatment dynamics that can better inform revenue forecasts, market share tracking, marketing resourcing, salesforce sizing, and more.
Komodo Health’s National Drug Projections: Advancing Data-Driven Insights for Healthcare and Life Sciences
Komodo Health, a leading technology platform, is redefining real-world data analytics by integrating artificial intelligence with the industry’s most comprehensive view of patient encounters. Its innovative solutions bridge individual patient journeys with large-scale health outcomes, empowering stakeholders across Life Sciences, payers, providers, and developers to generate actionable, patient-centric insights.
National Drug Projections: A Comprehensive View of Market Intelligence
Komodo’s National Drug Projections offers unparalleled insight into pharmacy benefit (retail and specialty) and medical benefit drugs, including brands, biosimilars, and generics. This advanced solution enables users to:
– Compare medications side-by-side, identifying market opportunities swiftly.
– Build customized reports on drug trends and market share, leveraging intelligence from over 10,000 therapies.
– Access transparent reports featuring projected vs. observed values, along with confidence intervals to guide strategic decisions.
Seamless Integration with Komodo’s Healthcare Map™
National Drug Projections integrates seamlessly with the Healthcare Map™—a robust platform featuring longitudinal, de-identified patient-level insights derived from Medicare claims, commercial claims, and health records from over 300 million individuals. By combining these insights with projected variables, organizations can:
– Accurately assess therapy volumes and forecast market success.
– Monitor competitive landscapes in real time.
– Develop data-driven strategies to close care gaps, manage disease burdens, and enhance cost-effectiveness.
User-Friendly Dashboards with Real-Time Analytics
Designed for accessibility across functions, National Drug Projections can be used as a standalone product or integrated into Komodo’s MapLab platform. Users of any data expertise level can select drugs of interest and generate real-time dashboards within minutes, featuring multiple variables and visualizations to inform strategic decisions.
Future Developments for Enhanced Market Insights
Komodo Health’s National Drug Projections is the foundation for an evolving product suite. Upcoming offerings, including IC-grade, subnational, and indication-based projections, will be launched through 2025, further enhancing the platform’s capabilities to meet emerging market needs.
By pairing clinical data with advanced AI-powered software, Komodo Health continues to drive a more value-driven healthcare system, supporting teams in Life Sciences and healthcare in optimizing brand strategies and improving patient outcomes at scale.
“National Drug Projections delivers actionable intelligence and a precise view on market dynamics to help Life Sciences companies make smarter decisions,” said Paul Gurney, Senior Vice President of Data Product, Komodo Health. “With robust and up-to-date projections, companies can track competitive performance, proactively adjust their strategies, optimize resource allocation, and better navigate market uncertainties — ultimately helping maximize market share and drive growth in a fast-evolving landscape.”
